Effectiveness of native vitamin D therapy in patients with chronic kidney disease stage 3 and hypovitaminosis D in Colombia, South America

dc.creatorRestrepo Valencia, Cesar A.
dc.creatorAguirre Arango, Jose V.
dc.creatorMusso, Carlos G.
dc.date.accessioned2020-01-17T14:39:23Z
dc.date.accessioned2022-11-14T19:44:47Z
dc.date.available2020-01-17T14:39:23Z
dc.date.available2022-11-14T19:44:47Z
dc.date.created2020-01-17T14:39:23Z
dc.date.issued2019
dc.identifier11787058
dc.identifierhttps://hdl.handle.net/20.500.12442/4533
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5182186
dc.description.abstractIn a high percentage of patients with chronic kidney disease (CKD) low levels of vitamin D are detected. The purpose of this study was to evaluate if the native vitamin D therapy (cholecalciferol) in the patients with stage 3 and hypovitaminosis D allows to modify markers of bone and mineral metabolism once normal serum levels have been achieved.
dc.languageeng
dc.publisherDovepress
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional
dc.sourceInternational Journal of Nephrology and Renovascular Disease
dc.sourceVol. 12 (2019)
dc.sourcehttps://doi.org/10.2147/IJNRD.S214194
dc.subjectVitamin D
dc.subjectCholecalciferol
dc.subjectChronic kidney disease
dc.subjectHypovitaminosis D
dc.titleEffectiveness of native vitamin D therapy in patients with chronic kidney disease stage 3 and hypovitaminosis D in Colombia, South America
dc.typearticle


Este ítem pertenece a la siguiente institución